FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023149007> ?p ?o ?g. }

• W2023149007 endingPage "33908" @default.
• W2023149007 startingPage "33905" @default.
• W2023149007 abstract "Glucose metabolism by pancreatic β and α cells is essential for stimulation of insulin secretion and inhibition of glucagon secretion. Studies using rodent islets have suggested that the ATP/ADP ratio serves as second messenger in β cells. This study compared the effects of glucose on glucose oxidation ([U-14C]glucose) and adenine nucleotides (luminometric method) in purified rat α and β cells. The rate of glucose oxidation at 1 mm glucose was higher in β than α cells (4.5-fold, i.e. ∼2-fold after normalization for cell size). It was more strongly stimulated by 10 mmglucose in β cells (9-fold) than in α cells (5-fold). At 1 mm glucose, ATP levels were similar in both cell types, which corresponds to an approximately 2-fold higher concentration in α cells (∼6.5 mm) than in β cells (∼3 mm). In β cells, glucose dose-dependently increased ATP and decreased ADP levels, causing a rise in the ATP/ADP ratio from 2.4 to 11.6 at 1 and 10 mm, respectively. In α cells, glucose did not affect ATP and ADP levels, and the ATP/ADP ratio remained stable around 7.5. In human islets, the ATP/ADP ratio progressively increased between 1 and 10 mm glucose. In duct cells, which often contaminate human islet preparations, an increase in the ATP/ADP ratio sometimes occurred between 1 and 3 mm glucose. In conclusion, the present observations establish that the regulation of glucagon secretion by glucose does not involve changes in α cell adenine nucleotides and further support the role of the ATP/ADP ratio in the control of insulin secretion. Glucose metabolism by pancreatic β and α cells is essential for stimulation of insulin secretion and inhibition of glucagon secretion. Studies using rodent islets have suggested that the ATP/ADP ratio serves as second messenger in β cells. This study compared the effects of glucose on glucose oxidation ([U-14C]glucose) and adenine nucleotides (luminometric method) in purified rat α and β cells. The rate of glucose oxidation at 1 mm glucose was higher in β than α cells (4.5-fold, i.e. ∼2-fold after normalization for cell size). It was more strongly stimulated by 10 mmglucose in β cells (9-fold) than in α cells (5-fold). At 1 mm glucose, ATP levels were similar in both cell types, which corresponds to an approximately 2-fold higher concentration in α cells (∼6.5 mm) than in β cells (∼3 mm). In β cells, glucose dose-dependently increased ATP and decreased ADP levels, causing a rise in the ATP/ADP ratio from 2.4 to 11.6 at 1 and 10 mm, respectively. In α cells, glucose did not affect ATP and ADP levels, and the ATP/ADP ratio remained stable around 7.5. In human islets, the ATP/ADP ratio progressively increased between 1 and 10 mm glucose. In duct cells, which often contaminate human islet preparations, an increase in the ATP/ADP ratio sometimes occurred between 1 and 3 mm glucose. In conclusion, the present observations establish that the regulation of glucagon secretion by glucose does not involve changes in α cell adenine nucleotides and further support the role of the ATP/ADP ratio in the control of insulin secretion. Glucose homeostasis is largely regulated in the endocrine pancreas through opposite effects of glucose on insulin and glucagon secretion. Pancreatic β cells are fuel sensors that adjust the rate of insulin secretion to the rate at which they metabolize glucose (reviewed in Refs. 1Newgard C.B. McGarry J.D. Annu. Rev. Biochem. 1995; 64: 689-719Crossref PubMed Scopus (494) Google Scholar, 2Prentki M. Eur. J. Endocrinol. 1996; 134: 272-286Crossref PubMed Scopus (189) Google Scholar, 3Matschinsky F.M. Diabetes. 1996; 45: 223-241Crossref PubMed Scopus (0) Google Scholar). Two major transduction pathways are involved. The first one uses ATP-sensitive K+ channels (K+-ATP channels) of the plasma membrane to transduce biochemical into biophysical signals. Thus, glucose metabolism causes closure of these K+-ATP channels, which leads to membrane depolarization, opening of voltage-dependent Ca2+ channels, and acceleration of Ca2+ influx. The resulting rise in cytoplasmic Ca2+ concentration ([Ca2+]i) then triggers exocytosis of insulin granules (reviewed in Refs. 4Ashcroft F.M. Proks P. Smith P.A. Ämmälä C. Bokvist K. Rorsman P. J. Cell. Biochem. 1994; 55 (suppl.): 54-65Crossref PubMed Scopus (244) Google Scholar, 5Wollheim C.B. Lang J. Regazzi R. Diabetes Rev. 1996; 4: 276-297Google Scholar, 6Cook D.L. Taborsky G.J. Porte D. Sherwin R.S. Ellenberg and Rifkin's Diabetes Mellitus. 5th Ed. Appleton & Lange, Stamford, CT1997: 49-73Google Scholar). The second pathway, known as the K+-ATP channel-independent pathway, increases the effectiveness of Ca2+ on exocytosis by as yet incompletely elucidated mechanisms (7Gembal M. Gilon P. Henquin J.C. J. Clin. Invest. 1992; 89: 1288-1295Crossref PubMed Scopus (426) Google Scholar, 8Sato Y. Aizawa T. Komatsu M. Okada N. Yamada T. Diabetes. 1992; 41: 438-443Crossref PubMed Scopus (177) Google Scholar, 9Gembal M. Detimary P. Gilon P. Gao Z.Y. Henquin J.C. J. Clin. Invest. 1993; 91: 871-880Crossref PubMed Scopus (255) Google Scholar). Much less information is available on how glucose inhibits glucagon secretion from α cells (10Pipeleers D.G. Schuit F.C. Van Schravendijk C.F.H. Van De Winkel M. Endocrinology. 1985; 117: 817-823Crossref PubMed Scopus (164) Google Scholar). Measurements of glucose metabolism in α cell-rich islets (11Östenson C.G. Biochem. J. 1980; 188: 201-206Crossref PubMed Scopus (12) Google Scholar) and purified α cells (12Heimberg H. De Vos A. Pipeleers D. Thorens B. Schuit F. J. Biol. Chem. 1995; 270: 8971-8975Crossref PubMed Scopus (134) Google Scholar) and studies using metabolic inhibitors in whole islets or pancreas (13Weir G.C. Knowlton S.D. Martin D.B. J. Clin. Invest. 1974; 54: 1403-1412Crossref PubMed Scopus (90) Google Scholar, 14Östenson C.G. Agren A. Andersson A. Biochim. Biophys. Acta. 1980; 628: 152-160Crossref PubMed Scopus (8) Google Scholar, 15Hermansen K. Diabetes. 1981; 30: 203-210Crossref PubMed Scopus (23) Google Scholar) suggest that the inhibition of glucagon secretion is mediated by glucose metabolism in the α cells. Although early studies reported that glucose increases ATP levels in rodent islets (16Hellman B. Idahl L.-A. Danielsson A. Diabetes. 1969; 18: 509-516Crossref PubMed Scopus (71) Google Scholar, 17Ashcroft S.J.H. Weerasinghe L.C.C. Randle P.J. Biochem. J. 1973; 132: 223-231Crossref PubMed Scopus (233) Google Scholar), a rise in the ATP/ADP ratio was not a consistent finding (reviewed in Ref. 18Erecinska M. Bryla J. Michalik M. Meglasson M.D. Nelson D. Biochim. Biophys. Acta. 1992; 1101: 273-295Crossref PubMed Scopus (119) Google Scholar). Recently, we demonstrated that glucose causes a large, concentration-dependent increase in the ATP/ADP ratio in mouse islets and that this effect might be involved in the regulation of insulin secretion through both pathways (19Detimary P. Jonas J.C. Henquin J.C. J. Clin. Invest. 1995; 96: 1738-1745Crossref PubMed Scopus (108) Google Scholar, 20Detimary P. Van den Berghe G. Henquin J.C. J. Biol. Chem. 1996; 271: 20559-20565Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar). However, the changes measured in whole islets might not exactly reflect those occurring in β cells. It is also not known whether glucose affects adenine nucleotides in α cells. Measurements in islets isolated from animals made diabetic by destruction of most of their β cells with streptozotocin are indeed contradictory (21Matschinsky F.M. Pagliara A.S. Stillings S.N. Hover B.A. J. Clin. Invest. 1976; 58: 1193-1200Crossref PubMed Scopus (19) Google Scholar,22Östenson C.G. Diabetologia. 1979; 17: 325-330Crossref PubMed Scopus (43) Google Scholar). The present study compares the effect of glucose on adenine nucleotides in purified rat α and β cells (23Pipeleers D.G. in't Veld P.A. Van De Winkel M. Maes E. Schuit F.C. Gepts W. Endocrinology. 1985; 117: 806-816Crossref PubMed Scopus (324) Google Scholar). It also examines whether the changes observed in rodent cells are seen in isolated human islets. Rat islet β and α cells were purified from adult male Wistar rats by autofluorescence-activated cell sorting using previously described methods (23Pipeleers D.G. in't Veld P.A. Van De Winkel M. Maes E. Schuit F.C. Gepts W. Endocrinology. 1985; 117: 806-816Crossref PubMed Scopus (324) Google Scholar). In a first series of experiments, the islets were cultured overnight in Ham's F-10 medium supplemented with 2 mm glutamine, 10 mm glucose, 1% bovine albumin, and 5% fetal calf serum. They were then used to obtain three fractions of dispersed islet cells (20% α cells and 65% β cells), purified β cells (>90%), and non-β cells (∼70% α cells, 5–10% β cells, and 10–15% other cells). These purities were checked by immunocytochemistry (23Pipeleers D.G. in't Veld P.A. Van De Winkel M. Maes E. Schuit F.C. Gepts W. Endocrinology. 1985; 117: 806-816Crossref PubMed Scopus (324) Google Scholar). The three fractions were then incubated as described below for measurements of glucose oxidation and adenine nucleotide content. In a second series of experiments, the dispersion of islet cells and their purification immediately followed the islet isolation. Purified β cells were then cultured overnight in Ham's F-10 medium supplemented with 2 mm glutamine, 10 mmglucose, 2 mm CaCl2, and 1% bovine serum albumin. Non-β cells were first separated from β cells and then purified into α cells (>85% α cells, <5% β cells), which were then cultured overnight in Ham's F-10 medium supplemented with 2 mm glutamine, 6 mm glucose, and 1% bovine serum albumin. Purified β and α cells were then incubated as described below for measurement of glucose oxidation and adenine nucleotide content. The medium used was a bicarbonate-buffered solution that contained 120 mm NaCl, 4.8 mm KCl, 2.5 mmCaCl2, 1.2 mm MgCl2, 1 mm Na2HPO4, and 24 mmNaHCO3. It was gassed with O2:CO2(94:6) to maintain pH 7.4 and was supplemented with 1% bovine serum albumin. Cell preparations were first washed twice with this medium before batches of 15,000–50,000 cells were incubated for 1 h in 375 μl of medium supplemented with different glucose concentrations. The incubation was stopped by the addition of 125 μl of trichloroacetic acid to a final concentration of 5%. The samples were then processed, and ATP and ADP were measured by a luminometric method exactly as described previously (20Detimary P. Van den Berghe G. Henquin J.C. J. Biol. Chem. 1996; 271: 20559-20565Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar). Batches of ∼100,000 cells from the different cellular fractions were incubated for 2 h in 100 μl of Earle's-Hepes buffer (24Schuit F. De Vos A. Farfari S. Moens K. Pipeleers D. Brun T. Prentki M. J. Biol. Chem. 1997; 272: 18572-18579Abstract Full Text Full Text PDF PubMed Scopus (356) Google Scholar) containing the indicated concentration of glucose and supplemented with 25 μCi/ml [U-14C]glucose. The incubation was stopped by the addition of 20 μl of 1 nHCl and 14CO2 was trapped with hydroxyhyamine. Other details of the method have been published (24Schuit F. De Vos A. Farfari S. Moens K. Pipeleers D. Brun T. Prentki M. J. Biol. Chem. 1997; 272: 18572-18579Abstract Full Text Full Text PDF PubMed Scopus (356) Google Scholar). Human pancreata were obtained from organ donors (19–61 years of age) within the framework of β Cell Transplant, a European Concerted Action on islet transplantation. After isolation, the islet preparations were cultured for 2–3 days as described elsewhere (25Ling Z. Pipeleers D.G. J. Clin. Invest. 1996; 98: 2805-2812Crossref PubMed Scopus (171) Google Scholar); their cellular composition was similar to that in our previous studies (25Ling Z. Pipeleers D.G. J. Clin. Invest. 1996; 98: 2805-2812Crossref PubMed Scopus (171) Google Scholar). They were then incubated for 1 h in bicarbonate-buffered medium containing the indicated glucose concentration before being processed for nucleotide measurements. The nucleotide content of the different cell preparations was measured after 1 h of incubation in the presence of various glucose concentrations (Fig. 1). In dispersed, unsorted, islet cells, ATP levels were 75% higher at 10 than 1 mm glucose (Fig. 1 A), whereas ADP levels were 45% lower (Fig. 1 B). This resulted in an increase in the ATP/ADP ratio from 3.8 at 1 mm glucose to 12.3 at 10 mm glucose (Fig. 1 C). ATP and ADP levels were slightly lower in purified β cells, but their relative changes were slightly larger, resulting in an increase in the ATP/ADP ratio from 3.2 to 14.8 between 1 and 10 mm glucose. In islet non-β cells, the ATP content was similar to that in β cells at 1 mm glucose but did not change when the glucose concentration was raised (Fig. 1 A). ADP levels were lower and decreased by 40% between 1 and 10 mm glucose. Thus, as compared with β cells, the ATP/ADP ratio in islet non-β cells was higher at 1 mm glucose but increased much less at 10 mm glucose. In no fraction were ATP or ADP levels different between 10 and 20 mm glucose. The rate of glucose oxidation was similar in β cells and unsorted islet cells; it increased 8-fold (β cells) and 6-fold (islet cells) when the concentration of glucose was raised from 1 to 10 mm (Fig. 1 D). The rate of glucose oxidation was lower in non-β cells than in β cells, both at low and high glucose; it increased 4-fold between 1 and 10 mm glucose. The islet non-β cell fraction is enriched in α cells but may contain up to 15% β cells and up to 20% other cell types (12Heimberg H. De Vos A. Pipeleers D. Thorens B. Schuit F. J. Biol. Chem. 1995; 270: 8971-8975Crossref PubMed Scopus (134) Google Scholar). The observed changes in glucose oxidation and nucleotide levels might thus take place, at least in part, in cells other than the α cells. We therefore purified the islet non-β cells into a fraction containing over 80% α cells. Fig. 2 Ashows that the ATP content of α and β cells was similar after incubation in 1 mm glucose and that glucose increased this content more than 2-fold in β cells without affecting it in α cells. In β cells, ADP levels decreased when the glucose concentration was raised (Fig. 2 B). The ADP content of α cells was 3-fold lower and did not change with the glucose concentration. As a result, the ATP/ADP ratio in β cells increased more than 4-fold between 1 and 10 mm glucose, whereas the elevated ratio in α cells at low glucose was not modified by a higher glucose concentration (Fig. 2 C). All changes occurring in β cells between 1 and 5 mm glucose were significant (p < 0.05 or less), but there was no difference between measurements at 10 and 20 mm glucose. The rate of glucose oxidation was higher in β than α cells (Fig.2 D). The difference was larger at 10 mm glucose (8-fold) than at 1 mm glucose (4.5-fold) because the oxidation rate was more strongly increased by glucose in β cells (9-fold) than in α cells (5-fold). In human islets, glucose increased the ATP/ADP ratio dose-dependently (Fig. 3). Because these preparations can contain up to 40% non-endocrine cells (mainly duct cells), we also measured the effects of glucose on the ATP/ADP ratio in duct cells. This ratio increased between 1 and 3 mm glucose and then plateaued; for unknown reasons the increase was observed in only four of seven preparations. The consequence is that the observed rise in ATP/ADP ratio in human islet preparations may partly reflect changes occurring in duct cells, at least between 1 and 3 mm glucose. The dotted line in Fig. 3 shows calculated values for islet cells after correction for events in 20% contaminating duct cells. The present study shows that glucose exerts strikingly different effects on adenine nucleotides in insulin- and glucagon-secreting cells. It does not change the ATP/ADP ratio in α cells and increases it in β cells from the rat. The study also establishes that glucose increases the ATP/ADP ratio in human islets. Two previous studies have used islets obtained from rat (21Matschinsky F.M. Pagliara A.S. Stillings S.N. Hover B.A. J. Clin. Invest. 1976; 58: 1193-1200Crossref PubMed Scopus (19) Google Scholar) or guinea pigs (22Östenson C.G. Diabetologia. 1979; 17: 325-330Crossref PubMed Scopus (43) Google Scholar) made β cell-deficient and diabetic with streptozotocin to estimate ATP levels in α cells. In one study no difference in islet ATP content was observed between 0 and 10 mm glucose (21Matschinsky F.M. Pagliara A.S. Stillings S.N. Hover B.A. J. Clin. Invest. 1976; 58: 1193-1200Crossref PubMed Scopus (19) Google Scholar), whereas a 25% increase occurred between 1.7–3.3 and 16.7 mm glucose in the other study (22Östenson C.G. Diabetologia. 1979; 17: 325-330Crossref PubMed Scopus (43) Google Scholar). ADP contents were not reported. The discrepancy between these studies and the increase in ATP levels that insulin caused in these α cell-rich islets of diabetic animals (22Östenson C.G. Diabetologia. 1979; 17: 325-330Crossref PubMed Scopus (43) Google Scholar, 26Matschinsky F.M. Pagliara A.S. Hover B.A. Pace C.S. Ferrendelli J.A. Williams A. J. Biol. Chem. 1976; 251: 6053-6061Abstract Full Text PDF PubMed Google Scholar) left unanswered the question of whether glucose influences adenine nucleotides in normal α cells. In preparations of islet non-β cells, the composition of which is comparable with that of α cell-enriched islets, glucose slightly increased the ATP/ADP ratio, mainly through a decrease in ADP. However, these changes can be ascribed to contaminating non-α cells, in particular 10–15% of residual β cells with their larger volume (12Heimberg H. De Vos A. Pipeleers D. Thorens B. Schuit F. J. Biol. Chem. 1995; 270: 8971-8975Crossref PubMed Scopus (134) Google Scholar). Thus, the experiments using purified α cells unambiguously showed that the ATP/ADP ratio is not influenced by glucose (1–10 mm) in glucagon-secreting cells from normal rats. The observation that the ATP/ADP ratio does not change in glucose-challenged α cells implies that the measurements in whole islets underestimate the actual changes occurring in β cells unless the ratio decreases in δ cells. This is very unlikely owing to the similarities of stimulus-secretion coupling in β and δ cells (15Hermansen K. Diabetes. 1981; 30: 203-210Crossref PubMed Scopus (23) Google Scholar). In practice, because 65% of β cells make up at least 80% of the islet volume in the rat (27Baetens D. Malaisse-Lagae F. Perrelet A. Orci L. Science. 1979; 206: 1323-1325Crossref PubMed Scopus (195) Google Scholar) and 80% of β cells make up close to 90% of the islet volume in the mouse (28Hedeskov C.J. Physiol. Rev. 1980; 60: 442-509Crossref PubMed Scopus (327) Google Scholar), the adenine nucleotide measurements in intact islets should satisfactorily reflect the changes occurring in β cells. However, in human islet preparations, the results may be variably influenced by the degree of contamination with duct cells in which the ATP/ADP ratio is influenced by glucose, at least in the low concentration range (1–3 mm). Pancreatic α and β cells have different sizes that must be taken into account in a comparison of their nucleotide contents. The intracellular space is about 2.3-fold larger in β than in non-β cells from the rat (620 versus 270 pl/103 cells) (12Heimberg H. De Vos A. Pipeleers D. Thorens B. Schuit F. J. Biol. Chem. 1995; 270: 8971-8975Crossref PubMed Scopus (134) Google Scholar, 29Gorus F.K. Malaisse W.J. Pipeleers D.G. J. Biol. Chem. 1984; 259: 1196-1200Abstract Full Text PDF PubMed Google Scholar). From these values it can be calculated that the ATP concentration increased from ∼3 to ∼7 mm in β cells and remained around 6.5 mm in α cells when the concentration of glucose was raised from 1 to 10 mm. Conversely, the concentration of total ADP decreased from ∼1.2 to 0.6 mm in β cells and was stable around 0.9 mm in α cells. It is important to realize that these values do not exactly correspond to the nucleotide concentrations in the cytoplasm. ATP and ADP, in a ratio close to 1.0, are present in insulin-containing granules (30Leitner J.W. Sussman K.E. Vatter A.E. Schneider F.H. Endocrinology. 1975; 95: 662-677Crossref Scopus (117) Google Scholar, 31Hutton J.C. Penn E.J. Peshavaria M. Biochem. J. 1983; 210: 297-305Crossref PubMed Scopus (167) Google Scholar, 32Detimary P. Jonas J.C. Henquin J.C. Endocrinology. 1996; 137: 4671-4676Crossref PubMed Scopus (76) Google Scholar). It is likely that adenine nucleotides are also present in glucagon-containing granules, but this has not been directly demonstrated. Another possible confounding factor is the degree of granulation of the two cell types. If one postulates that the relative granular pool of adenine nucleotides is similar in both cell types, α and β cells would seem to have similar cytoplasmic concentrations of ATP in the presence of high glucose. The peculiar feature of β cells appears to be an inability to maintain these high values when the concentration of glucose decreases, but the fact that substantial changes in the ATP/ADP ratio occur between 10 and 5 mmglucose clearly indicates that they do not express mere suffering of fuel-deprived cells. The metabolic organization of α and β cells has recently been compared (12Heimberg H. De Vos A. Pipeleers D. Thorens B. Schuit F. J. Biol. Chem. 1995; 270: 8971-8975Crossref PubMed Scopus (134) Google Scholar, 24Schuit F. De Vos A. Farfari S. Moens K. Pipeleers D. Brun T. Prentki M. J. Biol. Chem. 1997; 272: 18572-18579Abstract Full Text Full Text PDF PubMed Scopus (356) Google Scholar). After normalization for the differences in cell volume, the rate of glycolysis is similar probably because of the presence of a glucokinase in both cell types (33Heimberg H. De Vos A. Moens K. Quartier E. Bouwens L. Pipeleers D. Van Schaftingen E. Madsen O. Schuit F. Proc. Natl. Acad. Sci. U. S. A. 1996; 93: 7036-7041Crossref PubMed Scopus (119) Google Scholar). However, the ratio of lactate dehydrogenase/mitochondrial glycerol-3-phosphate dehydrogenase is lower in β cells than in α cells, β cells express much more pyruvate carboxylase than α cells, and glycolysis is largely aerobic in β cells and anaerobic in α cells (24Schuit F. De Vos A. Farfari S. Moens K. Pipeleers D. Brun T. Prentki M. J. Biol. Chem. 1997; 272: 18572-18579Abstract Full Text Full Text PDF PubMed Scopus (356) Google Scholar). In the present study basal glucose oxidation (at 1 mm glucose) was lower in non-β and purified α cells than in β cells, but this difference is largely attenuated after correction for the difference in cell size. Upon stimulation with 10 mm glucose, the relative increase in oxidation was larger in β cells (8–9-fold) than in non-β or α cells (4–5-fold). A tight coupling of glycolysis with pyruvate oxidation and ATP production in mitochondria may explain why the ATP/ADP ratio changes so much with the glucose concentration in β cells. These variations and a high anaplerosis of glucose-derived carbons (24Schuit F. De Vos A. Farfari S. Moens K. Pipeleers D. Brun T. Prentki M. J. Biol. Chem. 1997; 272: 18572-18579Abstract Full Text Full Text PDF PubMed Scopus (356) Google Scholar) may be the two major metabolic features distinguishing α and β cells. The lack of effect of glucose on the ATP/ADP ratio in α cells is a general metabolic feature shared by many cell types (34Brunengraber H. Boutry M. Lowenstein J.M. J. Biol. Chem. 1973; 248: 2656-2669Abstract Full Text PDF PubMed Google Scholar, 35Van Schaftingen E. Hue L. Hers H.G. Biochem. J. 1980; 192: 263-271Crossref PubMed Scopus (55) Google Scholar, 36Nelson B.D. Kabir F. Muchiri P. Biochem. J. 1984; 219: 159-164Crossref PubMed Scopus (18) Google Scholar), whereas the large variations occurring in β cells are exceptional from a metabolic standpoint. It is therefore tempting to speculate that these variations have a functional significance. The changes in the ATP/ADP ratio induced by glucose may regulate insulin secretion via the K+-ATP channel-dependent and -independent pathways (20Detimary P. Van den Berghe G. Henquin J.C. J. Biol. Chem. 1996; 271: 20559-20565Abstract Full Text Full Text PDF PubMed Scopus (121) Google Scholar, 37Detimary P. Gilon P. Nenquin M. Henquin J.C. Biochem. J. 1994; 297: 455-461Crossref PubMed Scopus (76) Google Scholar). K+-ATP channels have not been identified in guinea pig α cells (38Rorsman P. Hellman B. J. Gen. Physiol. 1988; 91: 223-242Crossref PubMed Scopus (78) Google Scholar) but are present in rat α cells (39Ronner P. Higgins T.J. Kraebber M.J. Najafi H. Diabetes. 1991; 40 (Suppl. 1) (abstr.): 155Google Scholar, 40Bokvist K. Hoy M. Poulsen C.R. Buschard K. Gromada J. Diabetologia. 1998; 41 (Suppl. 1) (abstr.): 139Google Scholar). However, the data presented here and the characteristics of the α cell electrical activity (38Rorsman P. Hellman B. J. Gen. Physiol. 1988; 91: 223-242Crossref PubMed Scopus (78) Google Scholar, 40Bokvist K. Hoy M. Poulsen C.R. Buschard K. Gromada J. Diabetologia. 1998; 41 (Suppl. 1) (abstr.): 139Google Scholar) do not support a role for these channels in the regulation of glucagon secretion by glucose. Mechanisms other than changes in adenine nucleotides should be sought to explain how glucose inhibits glucagon secretion. The current model of stimulus-secretion coupling in the pancreatic β cell has been built on experiments with rodent islets. Studies with human islets have shown that it can largely be extrapolated to the human β cell. In particular, the key role of glucose metabolism in the control of K+-ATP channels, membrane potential, and cytoplasmic [Ca2+]i has been verified (41Misler S. Barnett D.W. Gillis K.D. Pressel D.M. Diabetes. 1992; 41: 1221-1228Crossref PubMed Google Scholar, 42Hellman B. Gylfe E. Bergsten P. Grapengiesser E. Lund P.E. Berts A. Tengholm A. Pipeleers D.G. Ling Z. Diabetologia. 1969; 37 (Suppl. 2): 11-20Google Scholar). The present study validates an additional important extrapolation: the metabolism of glucose in human islets is followed by an increase in the ATP/ADP ratio, which may thus play a universal role of second messenger in the regulation of insulin secretion. We thank the technical staff of β Cell Transplant and the VUB-Diabetes Research Center for preparing the human and rat cell preparations and F. Knockaert for assistance with the nucleotide assays." @default.
• W2023149007 created "2016-06-24" @default.
• W2023149007 creator A5007085960 @default.
• W2023149007 creator A5028616412 @default.
• W2023149007 creator A5037520065 @default.
• W2023149007 creator A5066952822 @default.
• W2023149007 creator A5076977607 @default.
• W2023149007 creator A5080456562 @default.
• W2023149007 date "1998-12-01" @default.
• W2023149007 modified "2023-10-06" @default.
• W2023149007 title "The Changes in Adenine Nucleotides Measured in Glucose-stimulated Rodent Islets Occur in β Cells but Not in α Cells and Are Also Observed in Human Islets" @default.
• W2023149007 cites W1578136772 @default.
• W2023149007 cites W1583213500 @default.
• W2023149007 cites W1609520994 @default.
• W2023149007 cites W1755621340 @default.
• W2023149007 cites W182934739 @default.
• W2023149007 cites W1892902405 @default.
• W2023149007 cites W1894223650 @default.
• W2023149007 cites W1963820874 @default.
• W2023149007 cites W1967616869 @default.
• W2023149007 cites W1977225925 @default.
• W2023149007 cites W1979946833 @default.
• W2023149007 cites W1985753071 @default.
• W2023149007 cites W1987417071 @default.
• W2023149007 cites W1996649880 @default.
• W2023149007 cites W1996679527 @default.
• W2023149007 cites W2030386197 @default.
• W2023149007 cites W2052112129 @default.
• W2023149007 cites W2054714044 @default.
• W2023149007 cites W2056285142 @default.
• W2023149007 cites W2073635911 @default.
• W2023149007 cites W2076428562 @default.
• W2023149007 cites W2096514865 @default.
• W2023149007 cites W2122568821 @default.
• W2023149007 cites W2124662109 @default.
• W2023149007 cites W2124971376 @default.
• W2023149007 cites W2132727591 @default.
• W2023149007 cites W2140746123 @default.
• W2023149007 cites W2147809602 @default.
• W2023149007 cites W2155187305 @default.
• W2023149007 cites W2160424009 @default.
• W2023149007 cites W2161641259 @default.
• W2023149007 cites W2164861152 @default.
• W2023149007 cites W2178375292 @default.
• W2023149007 cites W2273325308 @default.
• W2023149007 cites W2399998347 @default.
• W2023149007 cites W2409310485 @default.
• W2023149007 cites W4250756743 @default.
• W2023149007 doi "https://doi.org/10.1074/jbc.273.51.33905" @default.
• W2023149007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9852040" @default.
• W2023149007 hasPublicationYear "1998" @default.
• W2023149007 type Work @default.
• W2023149007 sameAs 2023149007 @default.
• W2023149007 citedByCount "152" @default.
• W2023149007 countsByYear W20231490072012 @default.
• W2023149007 countsByYear W20231490072013 @default.
• W2023149007 countsByYear W20231490072014 @default.
• W2023149007 countsByYear W20231490072015 @default.
• W2023149007 countsByYear W20231490072016 @default.
• W2023149007 countsByYear W20231490072018 @default.
• W2023149007 countsByYear W20231490072019 @default.
• W2023149007 countsByYear W20231490072020 @default.
• W2023149007 countsByYear W20231490072021 @default.
• W2023149007 countsByYear W20231490072022 @default.
• W2023149007 countsByYear W20231490072023 @default.
• W2023149007 crossrefType "journal-article" @default.
• W2023149007 hasAuthorship W2023149007A5007085960 @default.
• W2023149007 hasAuthorship W2023149007A5028616412 @default.
• W2023149007 hasAuthorship W2023149007A5037520065 @default.
• W2023149007 hasAuthorship W2023149007A5066952822 @default.
• W2023149007 hasAuthorship W2023149007A5076977607 @default.
• W2023149007 hasAuthorship W2023149007A5080456562 @default.
• W2023149007 hasBestOaLocation W20231490071 @default.
• W2023149007 hasConcept C104317684 @default.
• W2023149007 hasConcept C134018914 @default.
• W2023149007 hasConcept C153911025 @default.
• W2023149007 hasConcept C165220095 @default.
• W2023149007 hasConcept C185592680 @default.
• W2023149007 hasConcept C18903297 @default.
• W2023149007 hasConcept C2778914748 @default.
• W2023149007 hasConcept C2779306644 @default.
• W2023149007 hasConcept C512185932 @default.
• W2023149007 hasConcept C55493867 @default.
• W2023149007 hasConcept C86803240 @default.
• W2023149007 hasConcept C95444343 @default.
• W2023149007 hasConceptScore W2023149007C104317684 @default.
• W2023149007 hasConceptScore W2023149007C134018914 @default.
• W2023149007 hasConceptScore W2023149007C153911025 @default.
• W2023149007 hasConceptScore W2023149007C165220095 @default.
• W2023149007 hasConceptScore W2023149007C185592680 @default.
• W2023149007 hasConceptScore W2023149007C18903297 @default.
• W2023149007 hasConceptScore W2023149007C2778914748 @default.
• W2023149007 hasConceptScore W2023149007C2779306644 @default.
• W2023149007 hasConceptScore W2023149007C512185932 @default.
• W2023149007 hasConceptScore W2023149007C55493867 @default.
• W2023149007 hasConceptScore W2023149007C86803240 @default.
• W2023149007 hasConceptScore W2023149007C95444343 @default.
• W2023149007 hasIssue "51" @default.

• next